This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
A shortage of drugs may begin due to changes in government procurement in Russia
Russians may face a shortage of subsidized medicines after the introduction of a new principle of public procurement. According to manufacturers, it is necessary to revise the mechanism proposed by the Ministry of Industry and Trade, which will give priority to pharmaceutical companies with full-cycle production.
As they write "News", A corresponding letter with suggestions and concerns was sent by industry associations of drug manufacturers to the Prime Minister Mikhail Mishustin. After the first changes in state purchases of drugs, the industry representatives reminded, the shortage had already begun and some of the drugs had to be purchased later on an urgent basis.
The new rule "second extra" assumes that with state purchases of strategically important drugs, preferences will be received by companies that have a full cycle production with the synthesis of a substance in the EAEU. This would violate the principles of competition, which could lead to a shortage of drugs or the exit from the market of large manufacturers.
The Ministry of Industry and Trade believes that the innovation will allow localizing production, which means that Russia will become less dependent on the import of medicines. At the same time, about 8% of substances for the production of drugs are produced on the territory of the country. According to Sergey Shulyak, general director of DSM Group, it will not be possible to fully satisfy the producers' demand for pharmaceutical raw materials.